18.7
Xenetic Biosciences, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
13.7
FY23:
9.59
FY24:
6.59
FY25:
8.05
(positive)
Change from FY21 to FY25
millions USD
FY21:
1.09
FY22:
1.07
FY23:
1.02
FY24:
0.31
FY25:
0.31
Total assets
Change from FY21 to FY25
millions USD
FY21:
19.8
FY22:
14.7
FY23:
10.6
FY24:
6.90
FY25:
8.36
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.42
FY22:
1.07
FY23:
0.81
FY24:
0.89
FY25:
0.97
(negative)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
18.4
FY22:
13.6
FY23:
9.80
FY24:
6.01
FY25:
7.40
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
19.8
FY22:
14.7
FY23:
10.6
FY24:
6.90
FY25:
8.36
All amounts in millions USD